Evidence map›Paper›PMID 30535794›Full record

ArticleEuropean journal of nutrition2019

Coffee and tea drinking in relation to the risk of differentiated thyroid carcinoma: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

Raul Zamora-Ros, Muath A Alghamdi, Valerie Cayssials, Silvia Franceschi, Martin Almquist, Joakim Hennings, Maria Sandström, Konstantinos K Tsilidis, Elisabete Weiderpass, Marie-Christine Boutron-Ruault and 37 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in European journal of nutrition, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Epidemiology of Thyroid Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors at 20 institutions in 13 countries.

Raul Zamora-RosUnit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Av Gran Via 199-203, 08908, L'Hospitalet de Llobregat, Spain. rzamora@idibell.cat.ORCID http://orcid.org/0000-0002-6236-6804
Muath A AlghamdiUnit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Av Gran Via 199-203, 08908, L'Hospitalet de Llobregat, Spain.
Valerie CayssialsUnit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Av Gran Via 199-203, 08908, L'Hospitalet de Llobregat, Spain.ORCID http://orcid.org/0000-0003-4155-298X
Silvia FranceschiEpidemiology Unit, Aviano Cancer Center, Milan, Italy.
Martin AlmquistDepartment of Surgery, Skåne University Hospital Malmö, Lund University, Lund, Sweden.
Joakim HenningsDepartment of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.
Maria SandströmDepartment for Radiation Sciences, Umeå University, Umeå, Sweden.
Konstantinos K TsilidisDepartment of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
Elisabete WeiderpassDepartment of Community Medicine, Faculty of Health Sciences, UiT, The Arctic University of Tromsø, Tromsö, Norway.ORCID http://orcid.org/0000-0003-2237-0128
Marie-Christine Boutron-RuaultCESP, Université Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
Bodil Hammer BechSection for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
Kim OvervadSection for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
Anne TjønnelandUnit of Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark.
Kristina E N PetersenUnit of Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark.
Francesca Romana ManciniCESP, Université Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
Yahya Mahamat-SalehCESP, Université Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
Fabrice BonnetCESP, Université Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
Tilman KühnDivision of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
Renée T FortnerDivision of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany.
Heiner BoeingDepartment of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Antonia TrichopoulouHellenic Health Foundation, Athens, Greece.
Christina BamiaHellenic Health Foundation, Athens, Greece.
Georgia MartimianakiHellenic Health Foundation, Athens, Greece.
Giovanna MasalaCancer Risk Factors and Life-Style Epidemiology Unit, Cancer Research and Prevention Institute-ISPO, Florence, Italy.
Sara GrioniNutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Salvatore PanicoDepartment of Clinical and Experimental Medicine, Federico II University, Naples, Italy.
Rosario TuminoCancer Registry and Histopathology Unit, "Civic M.P. Arezzo" Hospital, ASP Ragusa, Ragusa, Italy.
Francesca FasanelliUnit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and University of Turin, Turin, Italy.
Guri SkeieDepartment of Community Medicine, Faculty of Health Sciences, UiT, The Arctic University of Tromsø, Tromsö, Norway.
Tonje BraatenDepartment of Community Medicine, Faculty of Health Sciences, UiT, The Arctic University of Tromsø, Tromsö, Norway.
Cristina LasherasDepartment of Functional Biology, Faculty of Medicine, University of Oviedo, Asturias, Spain.
Elena Salamanca-FernándezEscuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs.Granada, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.
Pilar AmianoCIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Maria-Dolores ChirlaqueCIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Aurelio BarricarteCIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Jonas ManjerDepartment of Surgery, Skåne University Hospital Malmö, Lund University, Lund, Sweden.
Peter WallströmNutrition Epidemiology Research Group, Department of Clinical Sciences, Lund University, Malmö, Sweden.
H Bas Bueno-de-MesquitaSchool of Public Health, Imperial College London, London, UK.
Petra H PeetersDepartment of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Kay-Thee KhawDepartment of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Nicholas J WarehamMRC Epidemiology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Julie A SchmidtCancer Epidemiology Unit, University of Oxford, Oxford, UK.
Dagfinn AuneSchool of Public Health, Imperial College London, London, UK.
Graham ByrnesInternational Agency for Research on Cancer (IARC), Lyon, France.
Augustin ScalbertInternational Agency for Research on Cancer (IARC), Lyon, France.ORCID http://orcid.org/0000-0001-6651-6710
Antonio AgudoUnit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Av Gran Via 199-203, 08908, L'Hospitalet de Llobregat, Spain.ORCID http://orcid.org/0000-0001-9900-5677
Sabina RinaldiInternational Agency for Research on Cancer (IARC), Lyon, France.
Université Paris-Sud · FRCentre international de recherche sur le cancer · FRInstitut d'Investigació Biomédica de Bellvitge · ESLund University · SEAarhus University · DKDanish Cancer Society · DKGerman Cancer Research Center · DENational and Kapodistrian University of Athens · GRUiT The Arctic University of Norway · NOUmeå University · SEUniversity Medical Center Utrecht · NLUniversity of Cambridge · GBAzienda Usl 8 Arezzo · ITBasque Government · ESCentro di Riferimento Oncologico · ITFederico II University Hospital · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITGerman Institute of Human Nutrition · DEHellenic Health Foundation · GRImam Mohammad ibn Saud Islamic University · SA

Funding

Cancer Research UK 14136Cancer Research UK 16491Medical Research Council G0401527Medical Research Council G1000143Medical Research Council MC_UU_12015/1Medical Research Council MR/M012190/1Medical Research Council MR/N003284/1World Health Organization 001
6 · The paper itself

Abstract

purposeCoffee and tea constituents have shown several anti-carcinogenic activities in cellular and animal studies, including against thyroid cancer (TC). However, epidemiological evidence is still limited and inconsistent. Therefore, we aimed to investigate this association in a large prospective study.

methodsThe study was conducted in the EPIC (European Prospective Investigation into Cancer and Nutrition) cohort, which included 476,108 adult men and women. Coffee and tea intakes were assessed through validated country-specific dietary questionnaires.

resultsDuring a mean follow-up of 14 years, 748 first incident differentiated TC cases (including 601 papillary and 109 follicular TC) were identified. Coffee consumption (per 100 mL/day) was not associated either with total differentiated TC risk (HR

conclusionsIn this large prospective study, coffee and tea consumptions were not associated with TC risk.

Indexed as

CoffeeNutrition AssessmentTeaAdenocarcinoma, PapillaryAdultAgedCohort StudiesEuropeFemaleHumansMaleMiddle AgedProspective StudiesRiskSurveys and QuestionnairesThyroid NeoplasmsCoffeeTeaCoffeeCohortEPICIntakeTeaThyroid cancer

Identifiers

PMID30535794
PMCPMC6850907
OpenAlexW2904596911

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.